Average Co-Inventor Count = 6.52
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biomarin Pharmaceutical Inc. (10 from 135 patents)
10 patents:
1. 12188058 - Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
2. 11254725 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
3. 10934534 - Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
4. 10301369 - Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins
5. 9845346 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
6. 9834587 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
7. 9834588 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
8. 9771408 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
9. 9376480 - Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
10. 8128925 - Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof